Literature DB >> 23495716

Coronary events in patients undergoing orthotopic liver transplantation: perioperative evaluation and management.

Asghar Ali1, Hem L Bhardwaj, Douglas M Heuman, Ion S Jovin.   

Abstract

Patients with advanced liver disease have a high prevalence of cardiac risk factors. The stress of liver transplant surgery predisposes these patients to major cardiac events, such as myocardial infarction or ventricular arrhythmias in addition to heart failure exacerbation. Liver transplant patients who experience coronary events in the perioperative period have a decreased five-yr survival rate. Cardiovascular risk stratification prior to liver transplant can be accomplished by dobutamine stress echocardiography, stress myocardial perfusion imaging, cardiac computed tomography, and coronary angiography. Pre-liver transplant management of cardiovascular pathology includes cardiovascular intervention like percutaneous coronary intervention, coronary bypass graft surgery, or medical management. Thorough screening and optimal management of underlying cardiovascular pathology and cardiovascular risk factors should decrease the incidence of new cardiac events in liver transplant recipients.
© 2013 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2013        PMID: 23495716     DOI: 10.1111/ctr.12113

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  4 in total

1.  Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: An evaluation of the evidence and consensus recommendations.

Authors:  Lisa B VanWagner; Matthew E Harinstein; James R Runo; Christopher Darling; Marina Serper; Shelley Hall; Jon A Kobashigawa; Laura L Hammel
Journal:  Am J Transplant       Date:  2017-11-18       Impact factor: 8.086

2.  Significance of Abnormal Myocardial Perfusion Scans in Candidates for Orthotopic Liver Transplantation.

Authors:  Atefe Esmaili; Saeed Farzanefar; Alireza Emami-Ardakani; Mehrshad Abbasi
Journal:  J Tehran Heart Cent       Date:  2017-01

3.  One-Year Outcomes of Percutaneous Coronary Intervention in Patients with End-Stage Liver Disease.

Authors:  Daniel Y Lu; Matthew D Saybolt; Daniel H Kiss; William H Matthai; Kimberly A Forde; Jay Giri; Robert L Wilensky
Journal:  Clin Med Insights Cardiol       Date:  2020-01-22

4.  LigaSure versus monopolar cautery for recipient hepatectomy in liver transplantation: a propensity score-matched analysis.

Authors:  Jeong-Moo Lee; Kwangpyo Hong; Eui Soo Han; Sanggyun Suh; Suyoung Hong; Suk Kyun Hong; YoungRok Choi; Nam-Joon Yi; Kwang-Woong Lee; Kyung-Suk Suh
Journal:  Ann Transl Med       Date:  2021-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.